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1. Introduction 
1.1 Cell biology of Chlamydia trachomatis (C. trachomatis) 
Chlamydia spp. are associated with a broad clinical spectrum of human diseases, including 
cardiovascular disease, and pulmonary, ocular and urogenital tract infections [1]. C. 
trachomatis is an obligate intracellular pathogen. The infection cycle starts with the entry 
of an infectious particle (elementary body or EB) into an epithelial cell. The EB-laden 
cytoplasmic vacuole (inclusion) migrates to the peri-Golgi region as the EB differentiates 
into a noninfectious but metabolically active reticulate body (RB). After replication, 
progeny RBs differentiate back to EBs for exiting the infected cells to disseminate to 
adjacent cells [2]. 
Over 18 serological variants (serovars) of C. trachomatis have been identified based on 
monoclonal antibody typing of the major outer membrane protein (MOMP). Serovars A, B, 
Ba and C cause trachoma, the leading cause of infectious blindness worldwide. Serovars Ba 
and C are also rarely associated with urogenital infections. Serovars D to K, Da, Ia and Ja are 
responsible for sexual transmitted diseases (STD) worldwide. The lymphogranuloma 
venereum (LGV) serovars L1-L3 and L2a, along with serovars D and G, are prevalent in 
anorectal infections unlike other genital serovars [3].  
The clinical course of C. trachomatis infection shows remarkable interindividual differences 
in transmission, symptomatic course, persistence or clearance of infection, and development 
of late complications. In general, the described differences in clinical course could be 
explained by interaction between the host (host factors), pathogen (virulence factors), and 
environmental factors (such as coinfections) [4]. 
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1.2 Urogenital infections with C. trachomatis in women and men 
C. trachomatis is the most prevalent bacterial cause of sexually transmitted infections in the 
world and can result in severe genital disease. Over 90 million chlamydial infections are 
detected annually worldwide and various studies have estimated that there are four to 
five million new cases of chlamydial infection each year in the USA alone [5, 6]. However, 
the reported incidence rates of genital chlamydial infections in the population likely are 
an underestimate because of the highly asymptomatic nature of the pathogen. 
Approximately 75% of infected women and 50% of infected men have asymptomatic 
urogenital infections, which represents a huge population of untreated individuals who 
can transmit the organism [5]. 
In women, genital tract infections caused by C. trachomatis cause major complications as 
pelvic inflammatory disease (PID), ectopic pregnancy, infertility and infant pneumonia. The 
risks factors vary in different population groups. However, in most cases, higher prevalence 
rates in sexually active individuals have been associated with younger age, unmarried 
status, low socioeconomic conditions and the use of oral contraceptives. C. trachomatis is 
recovered more often from women who acquire gonorrhea than from similarly exposed 
women who do not acquire gonorrhea [7, 8]. 
Non-gonococcal urethritis (NGU) is the most common clinical genital syndrome seen in the 
male, and C. trachomatis is the most important etiological agent for NGU. According to the 
Centers for Disease Control and Prevention (CDC), reported cases of men infected with C. 
trachomatis in the USA raised from 210,955 in 2004 to 315,065 in 2008, and infection rate per 
100,000 population in the same period raised from 144.0 to 209.1 [9]. 
Infection is primarily through penetrative sexual intercourse. In view of the increased practice 
of oral sex this has become a more important potential route of transmission for genital 
pathogens, including C. trachomatis, not only in homo/bisexual men, but also in heterosexual 
men [10, 11]. Cell-to-cell transmission, systemic dissemination, and autoinoculation of 
infectious fluids may contribute to chlamydial spread in the organism [12]. 
NGU may be complicated by epididymitis and orchitis. Thus, a role of C. trachomatis 
infection in the development of urethritis, epididymitis and orchitis is now well accepted, 
but a role for this pathogen in the development of prostatitis remains controversial [13, 14]. 
These disorders caused by C. trachomatis in men will be discussed in the next section. 
2. Clinical manifestations of male urogenital infection with C. trachomatis 
2.1 Urethritis 
The symptoms of urethritis are variable. In acute urethritis, the patient notices a urethral 
discharge and dysuria. Others have no symptoms or are symptom-free throughout the 
day and only notice a drop of pus in the morning prior to the first voiding of urine. 
Sometimes the glans or meatus urethrae may present with some redness as a sign of 
inflammation [15]. 
Urethritis can be caused by several microorganisms. The most relevant are Neisseria (N.) 
gonorrhoeae, C. trachomatis, Ureaplasma (U.) urealyticum, Mycoplasma (M.) genitalium and 
Trichomonas (T.) vaginalis [15, 16]. C. trachomatis is the most common pathogen identified in 
NGU; up to 42% of NGU cases may be caused by this bacterium [17]. Furthermore, there are 
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three cases of chlamydia per case of gonorrhea each year in the USA [18]. Overall, the 
reported frequency of C. trachomatis in male urethritis ranges from 15 to 56% [15, 19]. 
C. trachomatis infection appears to be equally prevalent in symptomatic and asymptomatic 
urethral disease, again reiterating the highly asymptomatic nature of this pathogen [13, 20, 
21]. When the infection is asymptomatic and undiagnosed, may have potentially serious 
consequences, like upper genital tract complications. 
2.2 Epididymitis 
The role of C. trachomatis as an etiological agent for the development of epididymitis also is 
widely accepted [13]. Untreated chlamydial infection of the urethra can spread to the 
epididymis. Patients usually have unilateral testicular pain with scrotal erythema, 
tenderness, or swelling over the epididymis [22]. The occurrence of chlamydial epididymitis 
is not always preceded by symptoms of urethritis and only in some cases they are 
accompanied by the increase of polymorphonuclear (PMN) leukocytes in urethral discharge. 
Chlamydial epididymitis is of milder course when compared to epididymitis of another 
etiology [23]. 
C. trachomatis is the causative agent in most cases of acute epididymitis in men younger than 
35 years, whereas common urinary tract pathogens account for the etiology of the majority 
of acute and chronic epididymal inflammations in men above this age [24-26]. For example, 
Zdrodowska-Stefanow et al. found C. trachomatis infection in 45.8% of patients of 
epididymitis below 35 years, whereas in older men the presence of the bacterium was 
detected in 6.7% [26]. 
2.3 Epididymo-orchitis 
Left untreated, the infection will progress from epididymitis to epididymo-orchitis. In the 
young patient it must be differentiated from torsion. In the older patient, subacute scrotal 
pain is most likely epididymo-orchitis. As in torsion, the testicle and/or epididymis is 
painful and tender; however, in this case, scrotal pain is more gradual in onset, there is no 
nausea or vomiting, the testicle is not high riding, and there is associated erythema and 
edema [27]. 
The causes of epididymo-orchitis reflect common causes of genitourinary infection in men 
based on particular age groups. In children and older men (>35 years), the most common 
cause of epididymitis is coliform organisms that result in bacteriuria. In contrast, the 
organisms that cause urethritis or STD are the common etiologies of epididymitis and 
orchitis in young adult men (<35 years) [28]. Chlamydial antigen has been detected in 
urethral or urine samples from 11 to 35% of men presenting with epididymo-orchitis [13]. 
2.4 Prostatitis 
Prostatitis is one of the most common urological disorders and can affect men of any age. 
Approximately one-third of all men during their lifetime will experience symptoms 
consistent with prostatitis [29]. The early classification of prostatitis described four 
syndromes for which pelvic pain in the male was the common factor [30]. In 1995 and 1998, 
two consensus meetings of the National Institutes of Health (NIH) attempted to refine the 
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four traditional classes of prostatitis. The NIH classification system designates categories I 
and II for cases in which bacteria clearly cause acute or chronic prostatitis, respectively. NIH 
category III incorporates the third (nonbacterial) and fourth (prostadynia) traditional classes 
and designates the entire cohort as Chronic Prostatitis/Chronic Pelvic Pain Syndrome 
(CP/CPPS), for which current clinical evidence does not indicate a clear bacterial cause. The 
fourth NIH category includes patients with prostatic inflammation in expressed prostatic 
secretions or on biopsy specimens performed for other clinical indications [31, 32]. 
In acute bacterial prostatitis, patients can present with voiding complaints, such as dysuria, 
frequency, urgency, or hesitancy. Other symptoms can include suprapubic pain, hematuria, 
or systemic symptoms such as fever, chills, nausea, vomiting, or malaise. Physical 
examination often reveals a warm, swollen, painful prostate. In chronic bacterial prostatitis a 
hallmark of a small minority of men is recurrent episodes of urinary tract infection. There 
may be irritative or lees often obstructive lower urinary tract symptoms and patients often 
complain of pain in perineum, lower abdomen, genitalia, back and lower rectum. These men 
also present with exacerbations of acute urinary infection with worsening of symptoms of 
bladder irritation, occasionally pyrexia, abdominal and loin pain. Pain is the most severe 
and commonly reported symptom in patients with CP/CPPS. The “classic” presentation is 
that of a patient who presents with pelvic, perineal, or genital pain associated with voiding 
and/or sexual dysfunction, characterized by a relapsing, remitting course. Finally, patients 
included in the fourth NIH category of prostatitis are asymptomatic, but there is evidence of 
inflammation, infection or both in prostate-specific specimens after massage and/or in 
cytological or histological investigations of prostatic biopsy specimens which have been 
obtained on account of elevation of the serum prostate-specific antigen (PSA). [29, 33- 35]. 
The most important agents of acute and chronic bacterial prostatitis are Escherichia coli 
(accounting for up to 87% of cases), Pseudomonas spp., Enterobacter spp., Proteus spp., 
Klebsiella spp. and Enterococcus spp. [35-37]. It is still under debate if and to what extent C. 
trachomatis can cause prostatitis. The definitive association between isolation of the 
bacterium and a prostatic origin is limited by the fact that diagnostic material from the 
prostate may reflect only urethral contamination. The prevalence of C. trachomatis infection 
in patients with prostatitis has ranged from 3 to 40% approximately [for reviews see 13, 23]. 
3. Which is the role of C. trachomatis in male infertility?  
3.1 Role of the inflammation of the urogenital tract 
Both acute and chronic infection and/or inflammation can cause partial or complete 
obstruction of sperm transport with, respectively, oligozoospermia or azoospermia. Bilateral 
obstruction of the epididymis is common after recurrent infection with C. trachomatis [38, 
39]. On the other hand, chronic inflammatory changes in the seminiferous tubules observed 
in orchitis, would be expected to disrupt the normal process of spermatogenesis and cause 
alterations both in sperm number and quality [40]. 
Besides of the anatomical consequences of obstruction, inflammation may act as a co-factor 
in the etiopathogenesis of infertility. Pressure-induced rupture of the epididymal duct or 
ductuli efferentes will disrupt the blood-testis barrier, activating an immunological defense 
reaction and inducing the production of anti-sperm antibodies (ASA) [38]. The presence of 
ASA can lead to the immobilization and/or agglutination of spermatozoa, which may 
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significantly impair sperm motility affecting acrosome reaction, cervical mucus penetration, 
zona pellucida binding, and sperm-oocyte function. Also, ASA can prevent implantation 
and/or arrest embryo development. ASAs were observed in the serum and/or in the seminal 
plasma or on the sperm surface in approximately 10% of infertile male partners [41, 42]. 
An increased prevalence of an autoimmune response to sperm in men with C. trachomatis in 
semen suggests that a subclinical chlamydial infection may activate an immune response to 
sperm [8]. Witkin et al. demonstrated that the presence of a humoral immune response to C. 
trachomatis is correlated with the development of an autoimmune response to spermatozoa 
[43]. Also, other authors found that chronic male genital infection with C. trachomatis could 
be associated with the development of ASA [44]. However, other groups found no 
association between chlamydial antibodies in semen and the presence of ASA [45], or 
between chronic inflammatory or infectious disease of the male reproductive tract with C. 
trachomatis and presence of ASA in semen [46]. 
On the other hand, heat shock proteins (HSP) are essential mammalian and bacterial stress 
proteins. At the cellular level, they act as chaperones, have important regulatory functions, 
and are considered to be an essential factor for reproduction. Members of the 60 kDa HSP 
family (HSP-60) in particular have been recognized as immunodominant antigens of many 
microbial pathogens, including C. trachomatis. Since the amino acid homology between 
many microbial HSP (e.g. chlamydial HSP-60) and the human 60 kDa HSP is high, the 
development of an autoimmune response to the human HSP-60 in susceptible individuals 
with chronic infections has been suggested [47-49]. According to one study, HSP-60 was 
present in a soluble form in semen primarily in men with evidence of immune system 
activation within their genital tract, and this presence correlated with the occurrence of 
antichlamydial immunoglobulin-A (IgA) [50]. However, Karinen et al. found that in male 
partners of subfertile couples serum antibody levels to HSP chlamydial antigens were lower 
than in controls [51]. Future research is necessary to assess the possible role of 
immunoresponse to bacterial HSP in reproductive function. 
Cytokines are regulatory proteins produced by leukocytes and other cells that control 
inflammation. Controversy exists as to whether elevated cytokine levels are related to semen 
quality. Kokab et al. found that men infected with C. trachomatis had lower percent 
progressive sperm motility, a higher leukocyte count, and a raised concentration of IL-8 in 
semen compared with men without infection. However, when median IL-6 concentrations 
in C. trachomatis-infected and –noninfected groups were compared, there was no statistical 
significance between them [52]. Eggert-Kruse et al. found only one subfertile male patient 
(1/137) who was positive for C. trachomatis and had high IL-8 concentration in seminal 
plasma [53]. Thus, more studies are necessary in this area. 
3.2 Direct interaction of C. trachomatis with sperm function and its impact on semen 
parameters 
Attachment of C. trachomatis to human spermatozoa was first observed in in vitro 
experiments using immunofluorescence tests with monoclonal antibodies to the bacterium, 
and transmission electron microscopy. Furthermore, sperm penetration tests revealed that 
spermatozoa, when progressing forward, can carry chlamydiae attached to them [54]. Also, 
electron microscope observations on male ejaculates revealed the presence of EBs and RBs of 
C. trachomatis in spermatozoa. After the passage of the infectious EB into the nucleus, all 
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stages of RB formation in the head of the spermatozoon were detected. Thus, was postulated 
that C. trachomatis can infect and be transmitted by spermatozoa to the female partner and 
cause infertility [55]. 
Friberg et al. observed that C. trachomatis was attached to spermatozoa recovered from the 
peritoneal cavity of patients with salpingitis, and suggested that spermatozoa may serve as 
vectors for C. trachomatis and spread this pathogen to the peritoneal surfaces of the uterus 
and fallopian tubes [56]. Also, Vigil et al. suggested that the possible effect of C. trachomatis 
on male fertility is not due to alterations in sperm quality or function, but rather to the 
transmission of the disease to female partners, causing inflammatory processes and 
promoting the generation of ASA [57]. 
However, other studies suggested that C. trachomatis may cause a direct damage to 
spermatozoon. Diquelou et al. observed abnormal sperm movements in men with positive 
culture for C. trachomatis [58]. Hosseinzadeh et al. showed that following incubation with 
EBs of C. trachomatis serovar E, the tyrosine phosphorylation of two major sperm epitopes of 
80 and 95 kDa is significantly increased. As a result, these authors hypothesized that C. 
trachomatis serovar E may compromise sperm function by accelerating sperm capacitation, 
since tyrosine phosphorylation of sperm proteins is closely associated with capacitation in 
vitro [59]. However, a further series of experiments demonstrated that serovar E was causing 
sperm death, suggesting that the chlamydial-induced increase in tyrosine phosphorylation 
was associated more with cell death than with capacitation [60]. Finally, in another work 
Hosseinzadeh et al. demonstrated that C. trachomatis-induced death of human spermatozoa 
is caused primarily by lipopolysaccharide (LPS) [61]. 
On the other hand, the impact of C. trachomatis on semen quality is controversial. In vitro 
studies (see above) show that co-incubation of spermatozoa with chlamydia causes a 
significant decline in numbers of motile sperm and results in premature sperm death. By, 
contrast, in vivo studies of C. trachomatis in men have provided conflicting evidence as to 
whether it is associated with reduced fertility [62]. Idahl et al. demonstrated that the 
presence of IgA and IgG antibodies to C. trachomatis in serum of male partners of infertile 
couples was significantly correlated with reduced motility of the spermatozoa, increased 
number of dead spermatozoa, higher prevalence of leukocytes in semen, decrease in sperm 
concentration, decrease in the number of progressive spermatozoa and a rise in the 
teratozoospermia index [63]. Veznik et al. examined 627 sperm samples. Sperm analysis 
showed significant differences between Chlamydia-positive and –negative samples. The 
Chlamydia-contaminated group showed lower values of normal sperm morphology, 
volume, concentration, motility and velocity, than the Chlamydia-negative samples [64]. 
However, Vigil et al. did not found significant differences between C. trachomatis-infected 
and –noninfected male partners of infertile couples in any of the sperm parameters assessed 
(sperm concentration, motility and morphology) [57]. Gdoura et al. reported that the mean 
values of seminal volume, sperm concentration, sperm viability, sperm motility, sperm 
morphology, and leukocyte count were not significantly related to the detection of C. 
trachomatis DNA in semen specimens of male partners of infertile couples [65]. Finally, 
another example of the controversial role of C. trachomatis in semen parameters is observed 
in prostatitis patients. Whereas Mazzoli et al. found that C. trachomatis affects sperm 
concentration, percentage of motile sperm and normal morphological forms in prostatitis 
patients [66], Motrich et al. found that chlamydial infection has no detrimental effects on 
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sperm quality [67]. Thus, for a number of reasons, mostly based on methodological aspects, 
the impact of C. trachomatis on semen parameters is controversial and further investigations 
should be performed to understand the disparities seen among the available studies. 
3.3 The controversial role of leukocytospermia on fertility 
Leukocytes are present throughout the male reproductive tract, are found in most ejaculates, 
and are thought to play an important role in immunosurveillance and phagocytic clearance 
of abnormal sperm [68]. PMN leukocytes are the most prevalent type of leukocyte in semen 
(50 to 60%), followed by macrophages/monocytes (20 to 30%), and T-lymphocytes (2 to 5%) 
[69]. Leukocytospermia is defined by the World Health Organization (WHO) as the presence 
of peroxidase-positive leukocytes in concentrations greater than 1x106/mL of semen [70]. 
Leukocytospermia may be due to either a genital tract infection or an inflammatory 
immunologic response. Other possible etiologies of leukocytospermia besides infection need 
to be considered. Environmental factors, such as smoking, alcohol consumption, and 
marijuana use, increase leukocytes in semen. Prolonged abstinence and certain sexual 
practices (use of vaginal products or anal intercourse) can produce leukocytospermia. 
Increased leukocytes in semen may be seen in men with abnormal spermatogenesis as a 
mechanism for the removal of defective sperm from the ejaculate. Finally, varicocele or 
vasovasostomy can result in a high number of leukocytes in semen [71, 72]. 
Neofytou et al. found a statistical significance between leukocytospermia and the presence 
of DNA of the Epstein-Barr virus (EBV) but not with the detection of other members of the 
Herpesviridae family [73]. Most studies show no correlation between the presence of 
leukocytes and bacteria in semen [74-76]. However, Punab et al. observed a positive 
correlation between the leukocyte count and the number of different bacteria detected in 
semen, and also between the leukocyte count and the total count of microorganisms in 
semen samples [77]. In fact, these authors along with Gdoura et al. [78] demonstrated that 
the WHO-defined cut-off point (1x106 leukocytes per mL) has very low sensitivity for 
discriminating between patients with and without significant bacteriospermia, as a more 
optimal sensitivity/specificity ratio appears at 0.2x106 leukocytes per mL of semen. 
EBs of C. trachomatis incubated in the presence of complement or specific antibody or both 
caused chemotaxis of human PMN leukocytes in vitro [79]. Four types of C. trachomatis-
leukocyte interaction were observed in vitro: (i) minimal to no bacterial binding, (ii) bacterial 
binding, followed by ingestion and high-level multiplication, (iii) bacterial binding, 
followed by ingestion but minimal multiplication, and (iv) bacterial binding, but minimal 
entrance or replication [80]. In vivo, was observed that men whose ejaculates were positive 
for chlamydial DNA had a significantly higher mean concentration of leukocytes than in 
those whose ejaculates were negative for the presence of DNA of the pathogen. 
Leukocytospermia was twice as common in men that were positive for chlamydial DNA, 
but it was not always associated with the presence of chlamydial DNA in semen [81]. Also, 
Idahl et al. showed that C. trachomatis serum IgA was significantly correlated with a higher 
prevalence of leukocytes in semen [63]. However, Bezold et al. found no difference in 
prevalence of C. trachomatis and other pathogens between asymptomatic male infertile 
patients with and without leukocytospermia [82]. Also, other authors found no relation 
between infection with C. trachomatis and leukocyte count in semen [65, 83, 84]. 
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The effect of leukocytospermia on male fertility is controversial: whereas some studies 
found an adverse effect of leukocytospermia on semen quality, others found no effect on 
semen parameters or even an improvement. This is probably due to different detection 
methods, different populations studied and to the fact that leukocyte subtypes in semen 
may have different functions [69, 85-88]. 
Thus, according to the reviewed literature, the impact of C. trachomatis on leukocyte count 
and male fertility is controversial. In previous works, we presented ultrastructural findings 
encountered in semen samples of infertile men infected with C. trachomatis and/or 
mycoplasmas: a) structural damage of spermatozoa, b) phagocytosis of damaged 
spermatozoa by leukocytes, c) destruction of bacteria by leukocytes, d) persistence of 
bacteria in leukocytes, and e) phagocytosis of damaged spermatozoa and leukocytes by 
epithelial cells of the genital tract. However, less than 1% of the samples analyzed presented 
leukocytospermia. Taken together, these data suggest that leukocytes might have a 
biological impact in fertility in some patients regardless of their count in semen [89-91]. 
Henkel et al. found that leukocyte counts <1x106/mL caused a significant decrease of 
motility and DNA integrity of spermatozoa [92]. Sharma et al. were unable to identify a safe 
lower limit for leukocyte count in semen because the presence of any leukocytes, no matter 
how few, was associated with elevated oxidative stress [93]. Aitken et al. concluded that low 
concentrations of leukocytes in the human ejaculate caused reactive oxygen species (ROS) 
generation and sperm damage [94]. Thus, the WHO threshold value for leukocytospermia 
has seriously been questioned by our data and those of others and should be re-evaluated. 
3.4 Sperm DNA damage 
3.4.1 Oxidative stress 
ROS are short-lived chemical intermediates which contain one or more electrons with 
unpaired spin. In order to overcome this state of unpaired electrons, they are highly and 
unspecifically reactive molecules able to oxidize proteins, lipids and nucleic acids. In many 
cases this oxidation causes irreversible damage to biological systems [95]. 
ROS leads to oxidative damage of the sperm membrane, which reduces fluidity of the 
membrane and disrupts the fusion events of the acrosome reaction. Sperm damaged by ROS 
lose motility, especially progressive motility, and have decreased viability and diminished 
fertilizing ability in the hamster egg sperm penetration assay and in in vitro fertilization [71]. 
Strong evidence suggests that high levels of ROS mediate the occurrence of high frequencies 
of single- and double-strand DNA breaks commonly observed in the spermatozoa of 
infertile men. Furthermore, studies in which the sperm was exposed to artificially produced 
ROS resulted in a significant increase in DNA damage in the form of modification of all 
bases, production of base-free sites, deletions, frame shifts, DNA cross-links and 
chromosomal rearrangements [96].  
ROS are associated with both increased apoptosis leading to spermatozoa DNA damage and 
decreased sperm variables (motility, concentration, and morphology) in semen of infertile 
men [97]. Also, several studies demonstrated an increased ROS generation in the ejaculates 
of infertile men [98, 99]. 
In the context of infections, either the pathogen itself may induce an increased generation of 
ROS or the invading inflammatory cells could generate ROS during the respiratory burst, 
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consuming the antioxidants present. In the male genital tract, ROS are generated by the 
pathogen, leukocytes (PMNs and macrophages) and defective spermatozoa [100, 101]. 
Studies with cell cultures infected with C. trachomatis demonstrated the production of ROS, 
which was associated with formation of lipid peroxides in host cell membranes [102]. More 
recently, other authors also have demonstrated that infection with C. trachomatis elicits the 
production of ROS [103, 104]. These data and the fact that C. trachomatis infection has been 
associated with a raised leukocyte count and the presence of damaged spermatozoa in 
semen (see precedent sections), indicate that C. trachomatis might have a role in male 
infertility trough the production of ROS.  
3.4.2 Apoptosis 
The apoptotic mode of cell death is an active and defined process which plays an important 
role in the development of multicellular organisms and in the regulation and maintenance 
of the cell populations in tissues upon physiological and pathological conditions [105]. 
Apoptosis controls the overproduction of male gametes and restricts the normal 
proliferation levels during conditions unsuitable for sperm development [106]. Also, 
apoptosis has been involved in the removal of abnormal cells from the testicles of patients 
with spermatogenetic failures [107]. 
Oosterhuis et al. found that about 20% of ejaculated spermatozoa are apoptotic, and that the 
concentration of spermatozoa is lower in men with more apoptotic spermatozoa [108]. 
Apoptosis has been observed in ejaculated spermatozoa from infertile men. Baccetti et al. 
observed that apoptosis is abnormally frequent in the sperm cells of the ejaculate of sterile 
men, and that it shows the classical biochemical and ultrastructural pattern in spermatozoa, 
spermatids, and apoptotic bodies [109]. Barroso et al. found that spermatozoa from infertile 
men display hallmarks of apoptosis, such as translocation of membrane phosphatidylserine 
(PS) and DNA strand breaks [110]. McVicar et al. found that the apoptotic marker Fas was 
expressed in sperm of infertile men, although DNA fragmentation was observed in all 
sperm of fertile and infertile men [111]. 
On the other hand, Shen et al. found that the detection of apoptotic cells in sperm of 
subfertile patients was inversely correlated to sperm motility and vitality, and positively 
correlated to total sperm counts, sperm concentration and abnormal sperm morphology 
[112]. These results support the abortive apoptosis theory, which establishes that apoptosis 
in mature sperm is initiated during spermatogenesis, after which some cells earmarked for 
elimination via apoptosis may escape the removal mechanism and contribute to poor sperm 
quality [113, 114]. 
Several studies show that C. trachomatis causes apoptosis of spermatozoon. Eley et al. 
observed that co-incubation of sperm with C. trachomatis LPS results in cellular death which 
is in part due to apoptosis [115]. Satta et al. observed that the experimental C. trachomatis 
infection causes sperm PS externalization and DNA fragmentation [116]. Gallegos et al. 
determined that patients with genitourinary infection by C. trachomatis and mycoplasmas 
have increased sperm DNA fragmentation in comparison with fertile controls [117]. We 
identified spermatozoa showing ultrastructural features resembling apoptosis in semen 
samples of infertile men infected with C. trachomatis and mycoplasmas. These features 
included: loose fibrillar-microgranular chromatin network, presence of vacuoles in the 
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chromatin, partially disrupted nuclear membranes and membranous bodies within the 
vacuoles of the chromatin [90, 91]. Lastly, Sellami et al. showed that inoculation of fertile 
male Swiss mice in the meatus urethra with C. trachomatis could lead to alteration of semen 
parameters, induction of apoptosis in spermatozoa, and decrease of the reproductive 
performance of male mice [118]. Taken together, these data support a role of C. trachomatis 
on sperm apoptosis. However, more research is needed to assess the real effect of this 
process in male fertility. 
3.4.3 Other phenomena associated with sperm DNA damage 
Besides of oxidative stress and apoptosis, defective sperm chromatin packaging may be 
another mechanism by which DNA damage arise in human spermatozoa. A variety of 
causes have been correlated with increased levels of sperm DNA damage, such as cigarette 
smoking, iatrogenic processes, malignancies (mainly testicular cancer, Hodgkin’s disease 
and leukemia), environmental toxicants, physical agents as radiation and heat, drugs, 
increasing male age, elevated body mass index and medical conditions as insulin dependent 
diabetes (for reviews see 96, 119, 120]. 
4. C. trachomatis coinfections and male infertility  
Urethritis has traditionally been classified as gonoccocal or NGU. However, the replacement 
of Gram stain testing of urethral discharge with combined laboratory testing for both 
gonococcal and chlamydial infections makes this distinction less important [16]. In addition, 
many studies have shown that some men with gonococcal urethritis are coinfected with C. 
trachomatis.  
The frequency of C. trachomatis and N. gonorrhoeae coinfection in men can vary dramatically 
depending on several factors, as the individual incidence and prevalence of each of these 
microorganisms in the studied population, the type of sample analyzed, the method used to 
detect the bacteria, etcetera. For example, whereas Barbosa et al. reported a coinfection 
prevalence of 4.4% in Brazil [121], Papadogeorgakis et al. found gonococcal coinfection in 
30% of the C. trachomatis-infected patients in Greece [122]. Kahn et al. found that 51% of 
males with gonorrhea were coinfected with chlamydia in US juvenile detention centers 
[123]. Thus, most of the studies are geographically limited and targeted to a certain portion 
of the population. However, the fact that some men with gonococcal urethritis are 
coinfected with C. trachomatis has led to the recommendation that men treated for 
gonoccocal urethritis should be treated routinely with a regimen that is effective against 
chlamydial infection [124]. 
Besides of C. trachomatis and N. gonorrhoeae, obligate pathogenic microorganisms in the male 
urogenital tract are Mycobacterium tuberculosis, Treponema pallidum, Haemophilus ducreyi, 
Klebsiella (Calymmatobacterium) granulomatis, herpes simplex virus (HSV) 2, human 
papilloma viruses (HPVs), and T. vaginalis. In systemic disease human immunodeficiency 
viruses, hepatitis B virus (HBV), hepatitis C virus, hepatitis D virus, and cytomegalovirus 
(CMV) may be excreted with semen, often in high concentrations [37]. Mixed infections are 
common and failure to diagnose and treat may lead to serious complications and continued 
transmission. 
About 200 established species have already been described within the class Mollicutes, and 
this number continues to rise [125]. Several Mollicutes species have been isolated from 
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humans. For six of them: U. urealyticum, M. hominis, M. genitalium, M. primatum, M. 
spermatophilum and M. penetrans, the genital tract is the main site of colonization [126]. These 
microorganisms can be found commensal in lower genitourinary tracts of sexually active 
men and women. Moreover, they cause many disorders such as nonchlamydial NGU [127, 
128]. The role of mycoplasmas and ureaplasmas in male infertility has been discussed 
controversially. Dieterle found no evidence that U. urealyticum has a significant impact on 
male infertility [129]. However, Zeighami et al. found that U. urealyticum was more common 
in semen of infertile men that in semen of healthy controls. Also, in infertile patients infected 
with ureaplasmas, the volume, count and morphology of semen samples were lower than in 
infertile patients negatives for the detection of the microorganisms [130]. Gdoura et al. 
reported that the comparison of the semen parameters of infertile men with and without 
genital mycoplasmas and ureaplasmas showed no significant differences, apart from the 
sperm concentration in the infection of M. hominis and M. genitalium and sperm morphology 
in the infection of M. hominis. Mixed species of mycoplasmas and ureaplasmas were 
detected in 6.7% of semen samples [131]. 
The identification of C. trachomatis in men infected with other sexually transmitted 
pathogens and their impact on male fertility have been reported in the literature. Gunyeli et 
al. determined the prevalence of C. trachomatis, M. hominis and U. urealyticum infections 
among infertile couples and effects of these infections on infertility. No difference was found 
between fertile and infertile couples in terms of the effects of these infections on sperm 
parameters and infertility. Moreover, the prevalence of these infections was found to be the 
same in fertile and infertile groups [132]. Gdoura et al. found that the mean values of 
seminal volume, sperm concentration, sperm viability, sperm motility, sperm morphology, 
and leukocyte count were not significantly related either to the detection of C. trachomatis 
DNA or to that of genital ureaplasma or mycoplasma DNA in semen specimens of 
asymptomatic male partners of infertile couples [65]. Bezold et al. detected the presence of 
DNA of CMV, HPV, human herpesvirus type 6, HSV, HBV, EBV, and C. trachomatis in 
semen from asymptomatic infertile men. The presence of DNA of the pathogens was 
associated with a decrease in sperm concentration, motile sperm concentration, total sperm 
count, and neutral alpha-glucosidase concentration [82]. Lastly, we found C. trachomatis and 
mycoplasmas coinfection in semen samples of 25% of the infertile men analyzed. 
Ultrastructural data suggested that leukocytes might have a role in fertility of some 
individuals infected with these bacteria [90, 91]. 
5. Diagnosis and treatment of C. trachomatis infections 
Laboratory testing of C. trachomatis has traditionally consisted of cell culture of inocula 
prepared from urogenital specimens and later, the antigen and nucleic acid detection 
technologies were developed [23]. Antibodies to Chlamydia spp. are best detected with a 
microimmunofluorescent (MIF) assay, but these assays are not widely available [133]. The 
MIF test is valuable in the diagnosis of urogenital infections but is expensive and labor-
intensive while the complement fixation (CF) test yields reliable results only for LGV. The 
value of Chlamydia-specific antibodies (IgM, IgG, IgA) in the diagnosis of urogenital 
infections using indirect immunofluorescence (IF) and immunoperoxidase (IPO) methods is 
limited since these antibodies are genus-specific and thus will also be elevated in infections 
with Chlamydophila pneumoniae [37]. 
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With regard to its high specificity, the bacteriological culture has been the method of choice 
for diagnosis. Another advantage is that these cultures maintain the viability of the 
microorganisms for additional studies such as genotyping or antimicrobial susceptibility 
tests. One disadvantage of the culture is the low sensitivity of 70-85%. Furthermore, the 
costs, the high level of technical expertise necessary and the time required to obtain results, 
are significant disadvantages of this method [8, 134]. Cycloheximide-treated McCoy or HeLa 
cell lines are used most frequently to isolate C. trachomatis. Centrifugation techniques appear 
to enhance absorption of chlamydiae to cells. Intracytoplasmic inclusions can be detected at 
48 to 72 hours with species-specific immunofluorescent monoclonal antibodies for C. 
trachomatis and Giemsa or iodine stains [133]. 
Rapid methods for diagnosis of a C. trachomatis infection include a direct fluorescent-
antibody stain (DFA) and enzyme immunoassays (EIA) to detect antigens of the bacterium. 
Both types of assay have low sensitivities compared to culture and DNA amplification 
methods. Compared to culture, the sensitivity of these assays, depending on many variables 
including the population examined and the culture technique used for comparison has been 
reported to vary from 50 to 90% [135]. However, the use of the DFA technique enables to 
detect C. trachomatis in situ in tissue biopsies, which is not possible with serological or DNA 
amplification methods (Gallegos et al., personal communication), and its specificity ranges 
from 98 to 99% [136]. 
Because of their high sensitivity and specificity, and their possible use for a large range of 
sample types, nucleic acid amplification tests (NAATs) are the tests of choice for the 
diagnosis of C. trachomatis genital infections. Several commercial NAATs are available and 
make use of different technologies: polymerase chain reaction (PCR) and real-time PCR, 
strand displacement amplification, transcription-mediated amplification, and nucleic acid 
sequence-based amplification. The major targets for amplification-based tests are generally 
multiple-copy genes, e.g. those carried by the cryptic plasmid of C. trachomatis, or gene 
products such as rRNAs [137]. 
A new genetic variant of C. trachomatis was discovered in Sweden in 2006. The variant has a 
377 base pair deletion in the plasmid which was the target for the commonly used NAATs. 
Therefore this new variant was initially not detected by the NAATs. So far the variant has 
been only occasionally detected outside Sweden or other Scandinavian countries. Many 
recent studies have focused on the new variant and disease syndromes associated with this 
variant. The clinical manifestations seem not to differ from the clinical manifestations 
caused by the wild types. Subsequently, NAATs have been modified so that this variant can 
now be detected by all NAATs commonly used in microbiology laboratories [138]. 
New guidelines for the treatment of patients with sexually transmitted chlamydial infection 
have been recently published. Recommended regimens are azithromycin 1 g orally in a 
single dose or doxycycline 100 mg orally twice a day for 7 days. Alternative regimens 
include erythromycin base 500 mg orally four times a day for 7 days, or erythromycin 
ethylsuccinate 800 mg orally four times a day for 7 days, or levofloxacin 500 mg orally once 
daily for 7 days, or ofloxacin 300 mg orally twice a day for 7 days [139]. 
Clinical trials demonstrate equivalent efficacy and tolerability of azithromycin versus 
doxycycline regimens for chlamydial infections. Each antibiotic regimen has advantages or 
disadvantages in terms of cost, convenience, and compliance, yet both regimens will remain 
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recommended as first-line therapy for uncomplicated chlamydial infection in nonpregnant 
individuals [140]. However, in patients who have erratic health-care-seeking behavior, poor 
treatment compliance, or unpredictable follow-up, azithromycin might be more cost-
effective in treating chlamydia because it enables the provision of a single-dose of directly 
observed therapy [139, 141].   
6. Conclusions 
Infection with C. trachomatis accounts for the most common bacterial sexually transmitted 
infection in the world. In men, C. trachomatis can cause urethritis, epididymitis, epididymo- 
orchitis and prostatitis, although asymptomatic infections are quite common. Both acute and 
chronic infection and/or inflammation can cause partial or complete obstruction of sperm 
transport with, respectively, oligozoospermia or azoospermia. A subclinical chlamydial 
infection may activate an immune response to sperm. Infection of the testis and prostate is 
implicated in a deterioration of sperm, possibly affecting fertility. Also, there is increasing 
evidence that the function of human spermatozoa can be significantly affected by direct 
exposure to the bacterium or by the host immune response induced by it. The role of 
leukocytospermia in the pathogenesis of male infertility remains controversial. The 
mechanisms by which leukocytes and C. trachomatis may lead to sperm damage include ROS 
generation and the induction of sperm apoptosis. On the other hand, the co-infection with C. 
trachomatis and other microorganisms may be a cause of the impairment of sperm quality, 
motility and function. Because of their high sensitivity, NAATs are the more reliable 
methods for the diagnosis of C. trachomatis infection. However, in tissue biopsies a DFA 
assay may be more useful to detect the bacterium. Treatments options for uncomplicated 
urogenital infections include therapy with azithromycin or doxycycline. 
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Nowadays, Chlamydia still represents a redoubtable pathogen. Among its consequences, the blindness in
children and severe impairment of reproductive health in adults are the most mutilating. Worldwide, it is
estimated that six million of people suffer from post-trachoma blindness and almost 90 million become sexually
infected each year. Due to its silent evolution and sexually transmission, the chlamydial infection can occur in
anyone. The book “Chlamydia - A Multifaceted Pathogen” contains an updated review of all-important issues
concerning the chlamydial infection. It comprises 18 chapters grouped in four major parts dealing with etiology
and pathogenicity, clinical aspects, diagnosis and prevention. The new molecular data about the pathogenicity
and the exhaustive presentation of clinical findings bring novelty to the book and improve our knowledge about
Chlamydia induced diseases.
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